Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosseti North Caucasus reported for 9 months of 2024 by RAS

10/30/24 MRKK

Rosinter reported for 9 months of 2024 by RAS

10/30/24 ROST

God Nisanov has withdrawn from the shareholders of Samolet Group

10/30/24 SMLT

APRI reported for 9 months of 2024 by RAS

10/30/24 APRI

RusHydro reported for 9 months of 2024 by RAS

10/30/24 HYDR

Lukoil reports for 9 months of 2024 by RAS

10/30/24 LKOH

Nizhnekamskshina reported for 9 months of 2024 by RAS

10/30/24 NKSH

Acron reports for 9 months of 2024 by RAS

10/30/24 AKRN

Lambumiz raised ₽802 million in its IPO

10/30/24 LMBZ

Aeroflot reported for 9 months of 2024 by RAS

10/30/24 AFLT